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Nonstress test (NST) is usually done in high-risk pregnancies, but can be applied in all pregnancies after 32 weeks,\[[@ref1][@ref2]\] and earlier from week 28.\[[@ref3]\]

High false-nonreactive results ranging from 75 to 99.8% are one of the limitations of this test.\[[@ref4][@ref5]\] However, most of the fetuses with a nonreactive result are not in danger, but due to sleeping cycle in a normal healthy fetus,\[[@ref6]\] increasing time from 20 to 40 min reduces the rate of false-nonreactive results.\[[@ref4]\]

So far, measures to reduce such false-nonreactive results, including vibroacoustic stimulating, intake of glucose by the mother, and abdominal manipulating to awake fetus have been followed.\[[@ref7][@ref8]\] Only vibroacoustic stimulation could significantly reduce the rate of false-nonreactive results.\[[@ref9][@ref10][@ref11][@ref12][@ref13][@ref14][@ref15]\] Application of low-frequency vibration stimuli on term fetuses can change the fetal state within 3 min. These changes are associated with long and fast heart rate variability and strong fetal movements.\[[@ref15]\]

In recent years, several studies on "halogen light" as an intervention that could stimulate the fetal heart reactivity in fetus have been done.\[[@ref8][@ref16][@ref17][@ref18][@ref19][@ref20][@ref21]\] In Caridi *et al*.\'s study, the earlier onset of Fetal Heart Rate (FHR) accelerations after halogen light stimulation prompted a more rapid reactive NST result. Bolnick *et al*. reported more reactive results in stimulus groups. The mean difference in time from the onset of the recorded stimulation to the first FHR accelerations, and a reactive result was shorter with either light or vibroacoustic stimulation compared with no stimulation. However, in Tanaboonyawat *et al*.\'s study, no statistical difference was observed between halogen light and no stimulation group.\[[@ref8][@ref17][@ref19]\]

The purpose of these studies was to increase the FHR in less time, and thus to reduce the false nonreactivity. Halogen light makes fetuses move head and leads to an increase in FHR through crossing the abdomen and uterine tissues and exposing the eyes of the fetus. So far, neither negative visual side effects in fetuses nor burning and inflammation in mothers have been reported.\[[@ref17][@ref19]\]

Although study reports noted the benefits of halogen light stimulation in NST, clinical trials have not yet concluded whether halogen light is more effective than vibroacoustic stimulation. The investigators aim to study vibroacoustic and halogen light stimulations on nonreactive fetal heart patterns to improve NST results through reducing the false-nonreactive results and time to reactivity.

While fetal well-being evaluation is one of the essential parts of prenatal care, the midwives' role is fully understood. Appling new approaches to pregnant women by midwives could promote maternal and fetal heath.
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This study is a clinical trial with registration ID in IRCT of IRCT201011275261N1.

Sampling was done in 2010 from April to July. The study population consisted of 100 pregnant women at 32-42 weeks of gestation. Inclusion criteria were singleton and cephalic pregnancy, absence of fetal anomalies, no labor pain and vaginal bleeding, no smoking 1 h before the test, absence of recognized psychiatric disorders including psychosis and anxiety, and the presence of a nonreactive FHR tracing in 20 min (absence of two adequate FHR accelerations). Women signed the informed consent form and were allocated randomly in *vibroacoustic stimulated NST* (VNST, *n* = 50) and *halogen light stimulated NST* (LNST, *n* = 50) groups.

For all women in left lateral position, hp Hewlett Pakard Series 50A (71834 Boeblingen, Germany) at 2 cm/min speed recorded FHR tracing. In the LNST group, the investigator used the flash light of 1,000,000 candle power as a halogen light source (CE Spotlight, Yuyao Shunye Electrical Appliances Co., Ltd, Yuyao, China) purchased locally. The power was equivalent to the halogen light source (CE Spotlight, Grand Globalization Group Co. Ltd., Bangkok, Thailand) previously reported for fetal light stimulation.\[[@ref19]\] The light was gently placed above mother symphysis to create a 10-cm-diameter surface for 10 sec. In the VNST group, a fetal vibratory stimulator (FS-1 Fetal Stimulator, Edan Instruments, Inc., Shekou, Nanshan Shenzhen, China) set on 80 Hz of frequency was applied gently to lower abdomen on the skin above mother symphysis for 3 sec.

The investigator (a postgraduate midwifery student) recorded the time and was ready to apply the stimulus.

The same investigator marked an arrow on the tracing, signifying the onset of intervention (halogen light or vibroacoustic). From either external source, if an adequate FHR acceleration of ≥15 beats/min above baseline was absent for ≥15 seconds, the stimulus would be repeated later up to maximum three times in 5 min intervals.

Our endpoint for comparison was nonreactive pattern to reactive changes. Then, the time elapsed from the stimulation till the onset of first adequate FHR acceleration, and the time elapsed from the stimulation to reactive pattern (end of second acceleration) were recorded. The interpretation of FHR tracing was performed by the same investigators and confirmed by an obstetrician blinded to interventions. NST results in the two groups were compared to Biophysical Profile (BPP) scores as a backup test. BPP was performed by a radiologist who was blinded to the interventions, evaluating four parameters including fetal breathing, fetal movement, fetal tone, and amniotic fluid index. Each parameter had a score of two, with a total score of eight if all were normal.

Assuming 40% false nonreactivity in halogen light stimulation and 70% in vibroacoustic stimulation, we calculated a sample size of at least 43. Due to probable dropping, we considered 50 cases in each group for 80% power at 5% significance.

Statistical comparisons were made using SPSS version 14. Mann whitney U and Chi-square tests were used to compare the two groups. Results were expressed as mean ± SD at 95% confidence interval (CI). Chi-square test and Fisher\'s exact test were used to compare results in the two groups and to BPP scores.
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The investigator enrolled 100 pregnant women (out of 850 NSTs) and allocated 50 women in VNST and 50 women in LNST groups.

The two groups were identical in maternal age, gestational age, and Body Mass Index (BMI). The indications for NST were maternal diabetes (66%), previous history of complications in the present pregnancy (normal condition at the test time) (66%), and unfavorable obstetrics conditions such as fetal growth restriction, reduced fetal movements, hypertension, and so on (17%) \[[Table 1](#T1){ref-type="table"}\]. Cardiovascular and lung problems, kidney and thyroid dysfunctions, and collagen tissue disorders were considered as medical indications for NST. Only one woman in VNST was with controlled hydronephrosis who had a nonreactive VNST and BPP of score 8. There was no significant difference in testing indications in the two groups.

###### 

Indications for testing in VNST and LNST
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[Figure 1](#F1){ref-type="fig"} displays the steps and manner of subjects' participation through the trial.

![Steps and manner of subjects' participation through the trial. NST: Nonstress test; VNST: Vibroacoustic stimulated NST; LNST: Halogen light stimulated NST; BPP: Biophysical profile](IJNMR-18-112-g002){#F1}

Since the trial was conducted in one stage, no pregnancy was lost. Out of 100 stimulated tests, 62% in VNST and 68% in LNST produced reactive results. There was no significant difference in both groups.

The effect of external stimulation on FHR response is shown in [Table 2](#T2){ref-type="table"}. The mean time elapsed from the stimulation to the onset of the first FHR acceleration in the two groups was not significantly different (VNST: 2.17 min; LNST: 2.27 min). In either group, almost 50% reached the first FHR acceleration in less than 2 min and 80% in 4 min. The mean time elapsed to reactive pattern (the end of second acceleration) was 4.91 min and 5.26 min in the VNST and LNST groups, respectively. In either group, most nonreactive patterns reached reactivity in 9 min (VNST: 96.8% and LNST: 88.3%). There was no significant difference between the two groups.

###### 

Fetal reactivity comparisons
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The results were compared to BPP in all 100 participants. About 90% of the participants gained a score of 8. Score \<8 belonged to five women in VNST and four women in LNST.

In VNST, two women had a score of 4. Score 0-2 was not reported. In either group, there was no significant relation between stimulated NST results and BPP scores. In VNST 89.5% and in LNST 87.5% of nonreactivity scored 8 in BPP. In the two groups, all nonreactive patterns remained despite three times of stimulation. Repeated stimulation had no effect in changing results. There was no significant relation between stimulated NST results and either gestational age or BMI.
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This is the first study focusing on the FHR responses to transabdominal halogen light stimulation, after 20 min of nonreactivity. The review of literature indicates the increasing reactive results followed by halogen light stimulation.\[[@ref8][@ref16][@ref17][@ref18][@ref19][@ref20][@ref21]\] However, altering nonreactive patterns to reactive results was the same in two different groups.

In either VNST or LNST group, the time to onset of the first acceleration was rather similarly shortened. In Bolnick *et al*.\'s study, the mean time to onset of reactivity was 4.4 min in vibroacoustic group and 4.3 min in halogen light group.\[[@ref8]\] Similarly, Caridi *et al*. and Thanaboonyawat *et al*. reported them to be 4.1 min and 5.4 min, respectively.\[[@ref17][@ref19]\] Our findings were considerably improved. Either intervention was similarly effective in reducing the time to onset of acceleration. Time to reactive pattern in Thanaboonyawat *et al*. and Caridi *et al*.\'s study was 10.5 min and 5.6 min, respectively.\[[@ref17][@ref19]\] The mean time to reactivity in Bolnick *et al*.\'s study was 9.4 min in vibroacoustic group and 9.1 min in halogen light.\[[@ref8]\] Our findings are obviously less similar or the same as the previous ones.

All 35% nonreactive patterns despite three times of stimulation in 20 min remained nonreactive. In one study, repeating stimulation infrequently happened (vibroacoustic group: 3.3%, halogen light: 5%).\[[@ref8]\] The need for repeating stimulation may be related to the different study methods. The frequency of interventions was the same in the two groups.

We did not observe the effect of external interventions on heights and widths of FHR accelerations. No effect was reported previously.\[[@ref8][@ref13][@ref14][@ref16][@ref17][@ref18][@ref19][@ref20][@ref21]\] In this study, early onset of FHR reactivity was partly related to the type of light source. Halogen light transmits more and has more power to penetrate tissue.\[[@ref20]\] Although NST and BPP are being performed in fetal well-being assessment, due to high false-nonreactive results reported along with reassuring BPP (score 8), there was no relation between stimulated NST results and BPP in either VNST or LNST group.

Factors such as gestational age and abdominal wall thickness may affect the fetal visual stimulation. Visual stimulation reactivity increases as the fetus grows up. Some findings noted fetuses of 37 weeks and older responded more to light stimulation.\[[@ref21]\] In term fetuses, test time was reduced by 2.4 min, but the difference was not significant.\[[@ref19]\]

Two different levels of gestational age (≥37 and \<37) did not affect the NST results. Lower abdominal thickness helps light transmission into uterus and increases the reactivity. Test time was reduced by 2.3 min in BMI \<27, but the difference was not significantly different.\[[@ref19]\] We considered BMI and indirectly maternal abdomen thickness to see the different responses; no effect of BMI in two levels (\<25 and ≥25 kg/m^2^) was statistically seen on NST results.

With regard to depth of penetration, halogen light intensity is half of that of sunlight, and 10 sec of exposure is brief. On the other hand, light distribution in uterus and amniotic fluid reduces the level of intensity.\[[@ref17]\] Exposure of 10 sec duration at 10 min intervals is safe for fetuses, and no thermal injury is caused to skin. There was no side effect and no contraindication for light stimulus test.\[[@ref19]\] In Bolnick\'s study, no thermal injury was seen through use of a mild light source. In none of the cases, FHR deceleration was reported and Apgar score was at least 8 in the fifth minute. Red reflex eye and hearing tests were normal in all neonates before discharge.\[[@ref8]\] We did not face any FHR instability and fetal bradycardia. In addition, there was no complication in the participants during a week after stimulus test.

C[ONCLUSION]{.smallcaps} {#sec1-5}
========================

This study is the first one to investigate the halogen light stimulation on 20-min nonreactive patterns. All NSTs were performed by the same investigator. We did not have a control group to see how results alter only by passing time. We do not know if the fetal eye positions could affect the fetal responsiveness to light; however, conditions were the same for all participants. Similar findings in comparing vibroacoustic and halogen light stimulation suggest halogen light stimulation approach can help as conventional NST complementary in fetal well-being evaluation as well as vibroacoustic stimulation. Applying vibroacoustic and halogen light stimulation, which are achievable, could be efficient and worthy upon midwives' decision and mothers' preference.
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